Clinical Evidence

In double blind placebo controlled studies, Vayarin has been clinically shown to help reduce restlessness, hyperactivity, impulsivity and inattention.

In a study with parents and teachers of ADHD children, Vayarin has also been shown to improve quality of life.

Our studies are held to high standards of testing for safety and efficacy. Results have been published in peer reviewed journals, such as the American Journal of Clinical Nutrition and European Psychiatry.

Improves Quality of Life
Reduces Hyperactivity, Restlessness, Implusivity and Inattention
Safe and Well-Tolerated

Learn more about our safety and efficacy studies.

You are about to enter a site that is for U.S. Healthcare Professionals only. By selecting "Yes" below, you certify that you are a Healthcare Professional and that you wish to proceed to the Healthcare Professionals Only section of this site. Products or treatments described on this site are available in the U.S. but may not be available in all other countries.

I am a licensed Healthcare Professional and wish to proceed to the Healthcare Professionals Only section of this site.